British watchdog rejects GSK’s lupus drug again
Britain’s healthcare cost watchdog has rejected GlaxoSmithKline’s lupus drug Benlysta a second time after the company offered an undisclosed discount, saying it still failed to offer good value for money.
Educator, Scholar, Author
Pop Culture with a Different Perspective
Feel the riddim.
The UNsettling reflections of a Decolonial Scientist
Just another emcee who gets free. Vessel of philanthropic vision fueled by theophilic purpose.
A great WordPress.com site
Follower of Jesus Christ. Disciple. Husband. Clemson Alum. Living life in light of eternity.
Writer :: Speaker :: Performer :: Teacher
Working and living the Mommy CEO life!
Totally free thoughts from a lawyer turned pastor
with Shawna Wingert
All Things Faith, Family, Food, Fun and more!
a radical approach to theology and politics
Lupus?! A wha dat?! 